1Omnignostica Ltd, 3421 Höflein at the Danube, Austria
2Department of Vascular Biology and Thrombosis Research, Medical University of Vienna, Austria
3LDN Ltd, Nordhorn, Germany
4RD-Ratio Diagnostics, Frankfurt, Germany
5Otto Loewi Research Center, Division of Physiological Chemistry, Medical University of Graz, Neue Stiftingtalstraße 6 HBK M1/D3, 8010 Graz, Austria
*Corresponding author: Willibald Wonisch, Omnignostica Ltd, A-3421 Höflein at the Danube, Austria
Submission: November 9, 2022; Published: November 28, 202
Volume2 Issue2November , 2022
Background: Activating the specific immune system by vaccination against COVID-19 is crucial to strive
against this pandemic. Constant and efficient monitoring of IgG antibody titres is valuable for evaluating
immunizations. However, serum or plasma samples, commonly used in follow-up active immunizations,
require a visit to the doctor´s office to be handled as a biohazard and need cold chain transportation and
storage.
Methods: In contrast, dry blood spots can be self-collected and represent a minimal biohazard potential,
even if they contain human pathogenic viruses. Blood sampling was performed on 12 volunteers (8
females) for six months after vaccination. Whole blood drops from a finger pulp were applied on filter
paper cards or collected in a Microvette for serum samples. Analysis was performed with a COVID-19
enzyme-linked immunosorbent assay.
Results: The comparison between dry blood spots and serum samples yielded similar results for SARSCoV-
2 IgG antibody titres. Daily blood sampling from the same subject revealed an initial boost in the
generation of antibody titres that descended after a peak level. Monitoring convalesced subjects after
a COVID-19 infection resulted in SARS-CoV-2 IgG antibody-titres of the same magnitude or higher
as vaccinated patients with at least three immunizations. An unvaccinated subject without infection
showed SARS-CoV-2 IgG antibody constantly titres below the cutoff level of the assay during the whole
observation period.
Conclusion: These results indicate that monitoring SARS-CoV-2 IgG antibody titres from dry blood spot
excisions is a user-friendly and reliable technique with a minimal biohazard risk regarding the transport
and analysis of these samples.
Keywords:Dry blood cards; COVID-19; Antibody titre; Populations immunity; SARS-CoV-2; Serum